Novavax
NVAX
213 hedge funds and large institutions have $2.84B invested in Novavax in 2020 Q2 according to their latest regulatory filings, with 117 funds opening new positions, 54 increasing their positions, 30 reducing their positions, and 20 closing their positions.
1,475% more capital invested
Capital invested by funds: $180M → $2.84B (+$2.66B)
485% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 20
82% more funds holding
Funds holding: 117 → 213 (+96)
80% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 30
29.33% more ownership
Funds ownership: 25.49% → 54.81% (+29%)
17% less call options, than puts
Call options by funds: $226M | Put options by funds: $272M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$182M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$98.7M |
| 3 |
BlackRock
New York
|
+$70.4M |
| 4 |
State Street
Boston,
Massachusetts
|
+$66.3M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$49.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$18.1M |
| 2 |
JP Morgan Chase
New York
|
-$15.9M |
| 3 |
Morgan Stanley
New York
|
-$7.17M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.72M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.46M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
226
Advisory Alpha
Holland,
Michigan
| – | -$6.22K | -305 | Closed |
|
227
Rockefeller Capital Management
New York
| – | -$3K | -235 | Closed |
|
|
WQ
228
Wealth Quarterback
Toms River,
New Jersey
| – | -$2.72K | -200 | Closed |
|
|
LFG
229
Larson Financial Group
St Louis,
Missouri
| – | -$1K | -41 | Closed |
|
|
IA
230
IFP Advisors
Tampa,
Florida
| – | -$497 | -13 | Closed |
|
|
LFG
231
LifePlan Financial Group
Dayton,
Ohio
| – | +$115 | +3 | New |
|
NVAX Hedge Fund Activity: Q2 2020 in Review
213 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2020, worth a combined $2.84B — up 1,475% from $180M a quarter earlier.
Buyers outnumbered sellers: 117 funds opened new NVAX positions and 20 closed out — a net gain of 97 holders — while 54 added to existing stakes and 30 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $182M. The largest seller was Millennium Management, cutting an estimated $18.1M.
- 213 institutional investors held Novavax (NVAX) as of Q2 2020, up from 117 in Q1 2020.
- Funds reported $2.84B of Novavax stock for Q2 2020, up 1,475% quarter-over-quarter.
- 117 funds opened new Novavax positions in Q2 2020 and 20 closed out, a net change of +97 holders.
- The largest Novavax buyer in Q2 2020 was RA Capital Management, an estimated $182M added.
- The largest Novavax seller in Q2 2020 was Millennium Management, an estimated $18.1M sold.
Based on aggregated 13F filings for Q2 2020.